ZHX2 and liver cancer: ZHX2 counteracts liver cancer stem cell traits by inhibiting KDM2A-mediated demethylation of H3K36 at the promoter region of stemness-associated transcription factors, such as NANOG, SOX2, and OCT4 (35).